Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2500 participants
INTERVENTIONAL
2010-01-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study
NCT03259919
Glucose Metabolism in Different PCOS Phenotypes
NCT03204461
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
NCT00883259
Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
NCT00319293
Metformin in Pregnant PCOS Women
NCT00159536
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OGTT by randomization
Women without risk factors for GDM are offered OGTT in gestational week 28
OGTT by randomization
OGTT by indication
Women with risk factors for OGTT are offered diagnostic 2 hour OGTT in pregnancy week 28
OGTT by indication
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OGTT by randomization
OGTT by indication
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residents of the municipality of Odense
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region of Southern Denmark
OTHER
Municipality of Odense
OTHER_GOV
University of Southern Denmark
OTHER
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marianne Andersen
DMSci
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marianne Andersen, DMSci
Role: PRINCIPAL_INVESTIGATOR
Odense University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OdenseUH
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Al-Jorani H, Jensen RC, Jensen TK, Christesen HT, Jorgensen JS, Bacmeister L, Dechend R, Glintborg D, Jensen BL, Andersen MS. Diurnal Urinary Aldosterone Excretion and Potassium Intake During Pregnancy Are Associated With High Normal Blood Pressure in Early Childhood. J Am Heart Assoc. 2025 Jul 15;14(14):eJAHA2025042165T. doi: 10.1161/JAHA.124.042165. Epub 2025 Jul 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Glucose OBK
Identifier Type: OTHER
Identifier Source: secondary_id
GDM OBK
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.